Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network)

Systemic amyloidosis arises from monoclonal CD38+ plasma cells that produce misfolded immunoglobulin light chains, which form amyloid fibrils that are deposited into different tissues, leading to organ damage. Daratumumab is a human IgG/k monoclonal antibody that targets CD38, a glycoprotein uniform...

Descripción completa

Detalles Bibliográficos
Autores principales: Sammartano, Vincenzo, Antonioli, Elisabetta, Buda, Gabriele, Ciofini, Sara, Candi, Veronica, Pengue, Ludovica, Del Giudice, Maria Livia, Attucci, Irene, Bacchiarri, Francesca, Occhini, Ubaldo, Pirrotta, Maria Teresa, Perfetto, Federico, Bocchia, Monica, Gozzetti, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952680/
https://www.ncbi.nlm.nih.gov/pubmed/35330483
http://dx.doi.org/10.3390/jpm12030484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952680/
https://www.ncbi.nlm.nih.gov/pubmed/35330483
http://dx.doi.org/10.3390/jpm12030484

Ejemplares similares